![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Acs G, Pasha T, Zhang PJ. 2004. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. International Journal of Gynecological Pathology 23:110–118.
- Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, et al. 2014. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility. The American Journal of Surgical Pathology 38:189–196.
- Fadare O, Parkash V, Gwin K, Hanley KZ, Jarboe EA, Liang SX, et al. 2013. Utility of α-methylacyl-coenzyme – a racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas. Human Pathology 44:2814–2821.
- Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, et al. 2014. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma – diagnostic utility of HNF-1β and oestrogen receptor. Histopathology 64:585–596.
- Hoang LN, McConechy MK, Meng B, McIntyre JB, Ewanowich C, Gilks CB, et al. 2015. Targeted mutation analysis of endometrial clear cell carcinoma. Histopathology 66:664–674.
- Iwamoto M, Nakatani Y, Fugo K, Kishimoto T, Kiyokawa T. 2015. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium. Human Pathology 46:957–962.
- Kenny SL, McBride HA, Jamison J, McCluggage WG. 2012. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β. The American Journal of Surgical Pathology 36:799–807.